雷爾馬達治療公司
US ˙ NasdaqCM ˙ US75955J4022

SecurityRLMD / Relmada Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership60,000 shares
Latest Disclosed Value $ 289,800
Barclays Plc ownership in RLMD / Relmada Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 60,000 shares of Relmada Therapeutics, Inc. (US:RLMD) valued at $289,800 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 10,000 shares of Relmada Therapeutics, Inc.. This represents a change in shares of 500.00% during the quarter. The current value of the position is $378,600 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (RLMD) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

RLMD / Relmada Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F RELMADA THERAPEUTICS COM 75955J402 60,000 50,000 500.00 290 1,345.00 0.0001
2026-03-31 2025-09-30 13F/A-3 RELMADA THERAPEUTICS COM 75955J402 10,000 9,999 999,900.00 20 0.0000
2026-03-19 2025-09-30 13F/A-2 RELMADA THERAPEUTICS COM 75955J402 145,999 145,998 473 0.0001
2025-11-12 2025-09-30 13F RELMADA THERAPEUTICS COM 75955J402 10,000 9,999 20 0.0000
2026-02-27 2025-06-30 13F/A-2 RELMADA THERAPEUTICS COM 75955J402 1 1 0 0.0000
2025-08-14 2025-06-30 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 1 1 0 0.0000
2025-08-13 2025-06-30 13F RELMADA THERAPEUTICS COM 75955J402 1 1 0 0.0000
2026-03-17 2025-03-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 0 -145,999 -100.00 0 -100.00
2025-05-15 2025-03-31 13F RELMADA THERAPEUTICS COM 75955J402 0 -145,999 0 0.0000
2026-03-19 2024-12-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 145,999 0 0.00 76 -84.14 0.0000
2025-02-13 2024-12-31 13F RELMADA THERAPEUTICS COM 75955J402 145,999 0 0 0.0000
2026-03-31 2024-09-30 13F/A-2 RELMADA THERAPEUTICS COM 75955J402 145,999 0 0.00 473 8.24 0.0001
2024-11-19 2024-09-30 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 145,999 0 0 0.0001
2024-11-15 2024-09-30 13F RELMADA THERAPEUTICS COM 75955J402 145,999 0 0 0.0000
2026-03-23 2024-06-30 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 145,999 0 0.00 438 -35.55 0.0001
2024-08-14 2024-06-30 13F RELMADA THERAPEUTICS COM 75955J402 145,999 0 0 0.0001
2026-03-24 2024-03-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 145,999 0 0.00 679 12.25 0.0002
2024-05-15 2024-03-31 13F RELMADA THERAPEUTICS COM 75955J402 145,999 0 1 0.0002
2026-03-25 2023-12-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 145,999 0 0.00 604 38.22 0.0002
2024-02-15 2023-12-31 13F RELMADA THERAPEUTICS COM 75955J402 145,999 0 1 0.0002
2026-03-26 2023-09-30 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 145,999 0 0.00 438 21.73 0.0003
2023-11-07 2023-09-30 13F RELMADA THERAPEUTICS COM 75955J402 145,999 0 0 0.0003
2026-03-30 2023-06-30 13F/A-2 RELMADA THERAPEUTICS COM 75955J402 145,999 131,161 883.95 359 987.88 0.0002
2023-09-20 2023-06-30 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 145,999 131,161 0 0.0002
2023-08-03 2023-06-30 13F RELMADA THERAPEUTICS COM 75955J402 145,999 131,161 0 0.0002
2026-03-30 2023-03-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 14,838 5,411 57.40 34 3.13 0.0000
2023-05-04 2023-03-31 13F RELMADA THERAPEUTICS COM 75955J402 14,838 5,411 0 0.0000
2026-03-30 2022-12-31 13F/A-1 RELMADA THERAPEUTICS COM 75955J402 9,427 2,326 32.76 33 -87.83 0.0000
2023-02-13 2022-12-31 13F RELMADA THERAPEUTICS COM 75955J402 9,427 2,326 0 0.0000
2022-11-03 2022-09-30 13F RELMADA THERAPEUTICS COM 75955J402 7,101 -9,598 -57.48 263 -17.03 0.0003
2022-08-12 2022-06-30 13F RELMADA THERAPEUTICS COM 75955J402 16,699 14,999 882.29 317 589.13 0.0002
2022-05-16 2022-03-31 13F RELMADA THERAPEUTICS COM 75955J402 1,700 1,700 46 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-03-30 2023-03-31 13F/A RELMADA THERAPEUTICS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-04 2023-03-31 13F RELMADA THERAPEUTICS OPT Put 0 0 n/a n/a n/a
2026-03-30 2022-12-31 13F/A RELMADA THERAPEUTICS OPT Put 2,100 7 n/a n/a n/a
2023-02-13 2022-12-31 13F RELMADA THERAPEUTICS OPT Put 2,100 0 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.